12 completed. 12 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 12 |
| Phase 2 | 1 | Completed 1 |
Follow Sedation: new trials by email Literature Review of Sedation trials Research Report on Sedation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets HSK3486, voriconazole +HSK3486 - Anesthesia, Sedation | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 16 | 2019-12-14 | 2020-12-19 |
| A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 HSK3486, Propofol - Anesthesia, Sedation | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 16 | 2019-01-09 | 2020-01-09 |
| A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults. HSK3486 - Anesthesia, Sedation | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 6 | 2019-01-06 | 2019-10-28 |
| A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules HSK3486, rifampin , HSK3486 - Anesthesia, Sedation | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 16 | 2018-12-14 | 2019-08-20 |
| A Study Evaluating Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 and Etomidate for Induction of Anesthesia in Healthy Male Subjects HSK3486+ etomidate - General Anesthetic, Sedation | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 25 | 2016-11-30 | 2019-08-13 |
| A Study Evaluating Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Single IV Dose of HSK3486 Injectable Emulsion in Healthy Subjects. HSK3486 - Anesthesia, Sedation | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 24 | 2016-05-01 | 2020-03-03 |
| A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects HSK3486 - Anesthesia, Sedation | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 13 | 2015-11-10 | 2021-01-29 |
| Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Female Subjects. HSK3486, Propofol - Anesthesia, Sedation | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 25 | 2015-04-22 | 2019-07-31 |
| A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects. HSK3486, Propofol, Placebo - Anesthesia, Sedation | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 48 | 2014-04-13 | 2019-07-26 |
| Bioavailability of Dexmedetomidine After Intranasal Administration Intravenous dexmedetomidine, Intranasal dexmedetomidine - Sedation | Phase 1 | Completed | University of Turku | 7 | 2009-03-01 | 2010-01-13 |
| Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU Dexmedetomidine - Pharmacokinetics, Sedation | Phase 1 | Completed | Orion Corporation, Orion Pharma | 13 | 2008-09-01 | 2009-04-21 |
| Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers Remifentanil+clonidine - Acute Pain, Respiration | Phase 1 / Phase 2 | Completed | Oslo University Hospital | 12 | 2005-02-01 | 2011-07-06 |
Acute Pain (1) · Respiratory Aspiration (1)
Neurologic Manifestations (1) · Pain (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1)
HSK3486 (8) · Propofol (3) · Clonidine (1) · Dexmedetomidine (1) · Remifentanil (1) · Rifampin (1)
Sichuan Haisco Pharmaceutical Group Co., Ltd (9) · Orion Corporation, Orion Pharma (1) · Oslo University Hospital (1) · University of Turku (1)
China (4) · Finland (2) · Norway (1)
Jon B Bergmann, Ass. Prof. (1) · Klaus T Olkkola, MD, PhD, Professor (1) · Liyan Miao, PhD (1) · Timo Iirola (1) · Timo Iirola, MD (1)